Government advisers say U.S. adults who haven’t gotten any COVID-19 shots yet should consider a new option from Novavax. The protein based shot is a more traditional kind of vaccine
By Jacqueline Howard, CNN Vaccine advisers to the US Centers for Disease Control and Prevention voted 12-0 Tuesday to recommend Novavax’s Covid-19 vaccine for use as a two-dose primary series in adults.
The Centers for Disease Control and Prevention endorsed a committee's recommendation that the Novavax COVID-19 vaccine be used as a primary series option for adults.
The Centers for Disease Control and Prevention (CDC) has given Novavax approval for its two-dose vaccine series for adults. The vaccine is going to be available for those 18 years old and older. It is now the fourth coronavirus vaccine being made available in the United States.
Adults who haven't gotten any COVID-19 shots should consider the new option, the agency said Tuesday. The spike protein vaccine is more typical than the mRNA types being broadly used against COVID.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
CDC endorses more traditional Novavax COVID shot for adults | Since Then